Statins in pregnancy: Safety and perspectives of therapeutic applications

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 11, 2013, Pages 1439-1440

  Vlachadis, N ^a   Tsamadias, V ^a   Economou, E ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ATHEROSCLEROSIS; DRUG EFFICACY; DRUG SAFETY; HEALTH HAZARD; HUMAN; INTRAUTERINE GROWTH RETARDATION; LETTER; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY OUTCOME; TERATOGENS;

EID: 84883864559     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12279     Document Type: Letter

References (4)

1. Winterfeld U, Allignol A, Panchaud A, Rothuizen L, Merlob P, Cuppers-Maarschalkerweerd B, et al. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG 2013; 120: 463-71.
2. Costantine MM, Cleary K,; Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric-Fetal Pharmacology Research Units Network. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol 2013; 121: 349-53.
3. Villa PM, Kajantie E, Räikkönen K, Pesonen AK, Hämäläinen E, Vainio M, et al.; PREDO Study Group. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG 2013; 120: 64-74.
4. Athyros VG, Mikhailidis DP, Papageorgiou AA, Bouloukos VI, Pehlivanidis AN, Symeonidis AN, et al. Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study. Platelets 2005; 16: 65-71.